Back
Dyne Therapeutics Stock Price Chart
Sponsored
DYN
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
24
DYN
Dyne Therapeutics
Last Price:
$24.47
Seasonality Move:
12.85%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing slight buying pressure.
Dyne Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.84 | Sell |
20-day SMA: | 27.19 | Sell |
50-day SMA: | 29.27 | Sell |
200-day SMA: | 32.62 | Sell |
8-day EMA: | 24.88 | Sell |
20-day EMA: | 26.56 | Sell |
50-day EMA: | 29.09 | Sell |
200-day EMA: | 30.07 | Sell |
Dyne Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.62 | Sell |
Relative Strength Index (14 RSI): | 33.01 | Sell |
Chaikin Money Flow: | 94810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.42 - 29.98) | Sell |
Bollinger Bands (100): | (27.53 - 40.01) | Sell |
Dyne Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dyne Therapeutics Stock
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 23.97 while DYN 8-day simple moving average is 24.84, which is a Sell signal.
-
The stock price of DYN is 23.97 while Dyne Therapeutics 20-day SMA is 27.19, which makes it a Sell.
-
Dyne Therapeutics 50-day simple moving average is 29.27 while DYN share price is 23.97, making it a Sell technically.
-
DYN stock price is 23.97 and Dyne Therapeutics 200-day simple moving average is 32.62, creating a Sell signal.
DYN Technical Analysis vs Fundamental Analysis
Sell
24
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a SellThe current Dyne Therapeutics [DYN] share price is $23.97. The Score for DYN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Dyne Therapeutics Stock Info
Market Cap:
2.4B
Price in USD:
23.97
Share Volume:
187.3K
Dyne Therapeutics 52-Week Range
52-Week High:
47.45
52-Week Low:
12.06
Sell
24
Dyne Therapeutics (DYN)
is a Sell
Dyne Therapeutics Share Price Forecast
-
What is the Dyne Therapeutics stock price today?The Dyne Therapeutics stock price is 23.97 USD today.
-
Will DYN stock go up or go down?Dyne Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dyne Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dyne Therapeutics is overvalued.
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 23.97 while DYN 8-day exponential moving average is 24.88, which is a Sell signal.
-
The stock price of DYN is 23.97 while Dyne Therapeutics 20-day EMA is 26.56, which makes it a Sell.
-
Dyne Therapeutics 50-day exponential moving average is 29.09 while DYN share price is 23.97, making it a Sell technically.
-
DYN stock price is 23.97 and Dyne Therapeutics 200-day simple moving average is 30.07, creating a Sell signal.
Fundamental Analysis of Dyne Therapeutics
Is Dyne Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Dyne Therapeutics
Should I short Dyne Therapeutics stock?
-
DYN Moving Average Covergence Divergence (MACD) indicator is -1.62, suggesting Dyne Therapeutics is a Sell
-
Dyne Therapeutics Relative Strength Index (RSI) is 33.01, which suggest Dyne Therapeutics is oversold
-
The Bollinger Bands (25) for Dyne Therapeutics is (25.42 - 29.98), which suggest Dyne Therapeutics is a Sell
-
The Bollinger Bands (100) for Dyne Therapeutics is (27.53 - 40.01), which suggest Dyne Therapeutics is a Sell
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.